View Archive:
2012 |
2011 | 2010 |
2009 |
2008 |
2007 |
2006 |
2005 |
2004 |
2003 |
2002 |
2001 |
2000 |
1999 |
1998December 14, 2010
Cytokinetics to Present at the Deutsche Bank BIOFest Conference
December 13, 2010
Cytokinetics Announces Successful Completion of Phase IIA “Evidence of Effect” Clinical Trial of CK-2017357 in Patients with Amyotrophic Lateral Sclerosis
December 9, 2010
Cytokinetics to Host Investor Event on December 13, 2010
December 7, 2010
Cytokinetics Announces Presentation of Phase IIa “Evidence of Effect” Clinical Trial Data Relating to CK-2017357 in Patients with Amyotrophic Lateral Sclerosis
November 30, 2010
Cytokinetics to Present at Canaccord Genuity 5th Annual Cardiovascular, Diabetes and Obesity Conference
November 3, 2010
Cytokinetics to Present at November Healthcare Conferences
November 1, 2010
Cytokinetics Announces Changes to Its Board of Directors
October 28, 2010
Cytokinetics, Incorporated Reports Third Quarter 2010 Financial Results
October 27, 2010
Cytokinetics Announces the Selection of CK-2017357 to Windhover’s “Top 10 HOT SPACE Projects to Watch” List
October 21, 2010
Cytokinetics to Announce Third Quarter Results on October 28, 2010
October 1, 2010
Cytokinetics Announces Presentation of Clinical and Non-Clinical Data Relating to CK-2017357 at the 2010 Annual Aging Muscle Symposium
September 28, 2010
Cytokinetics to Present Clinical and Non-Clinical Data Relating to CK-2017357 at the 2010 Annual Aging Muscle Symposium
September 21, 2010
Cytokinetics Provides Update Regarding Omecamtiv Mecarbil Clinical Development Program
September 20, 2010
Cytokinetics to Present at the JMP Securities Healthcare Conference
September 14, 2010
Phase I Clinical Trial Data Relating to Omecamtiv Mecarbil Presented at the 2010 Heart Failure Society of America Annual Meeting
September 8, 2010
Additional Phase I Clinical Trial Data Related to Omecamtiv Mecarbil to be Presented at the 2010 Heart Failure Society of America Annual Meeting
August 4, 2010
Cytokinetics to Present at Canaccord Genuity Global Growth Conference
July 28, 2010
Cytokinetics, Incorporated Reports Second Quarter 2010 Financial Results
July 26, 2010
Cytokinetics Announces Award of Grant for Preclinical and Clinical Development of CK-2017357 in Myasthenia Gravis
July 22, 2010
Cytokinetics Announces Presentation of Phase I Data Relating to CK-2017357 at the XII International Congress on Neuromuscular Diseases
July 21, 2010
Cytokinetics to Announce Second Quarter Results on July 28, 2010
July 14, 2010
Cytokinetics to Present Phase I Data Relating to CK-2017357 at the XII International Congress on Neuromuscular Diseases
June 1, 2010
Cytokinetics to Present at June Healthcare Conferences
May 27, 2010
Cytokinetics Announces Opening of a Phase IIa “Evidence of Effect” Clinical Trial of CK-2017357 in Patients with Peripheral Artery Disease and Claudication
May 18, 2010
Cytokinetics Announces Presentation of Non-Clinical Data from Its Smooth Muscle Contractility Program at the American Thoracic Society’s 2010 International Conference
May 13, 2010
Cytokinetics to Hold Annual Meeting of Stockholders
May 11, 2010
Cytokinetics to Present Non-Clinical Data from Its Smooth Muscle Contractility Program at The American Thoracic Society’s 2010 International Conference
April 29, 2010
Cytokinetics, Incorporated Reports First Quarter 2010 Financial Results
April 28, 2010
Cytokinetics Announces Presentation of Non-clinical Data Relating to CK-2017357 at the Society for Vascular Medicine’s 2010 Annual Meeting
April 27, 2010
Cytokinetics to Present at May Healthcare Conferences
April 22, 2010
Cytokinetics to Announce First Quarter Results on April 29, 2010
April 21, 2010
Cytokinetics to Present Non-Clinical Data Relating to CK-2017357 at the Society for Vascular Medicine’s 2010 Annual Meeting
March 19, 2010
Cytokinetics Announces Opening of a Phase IIa “Evidence of Effect” Clinical Trial of CK-2017357 for Patients with Amyotrophic Lateral Sclerosis
March 16, 2010
Cytokinetics Announces Changes to Its Board of Directors
March 10, 2010
Cytokinetics Announces Orphan Drug Designation Granted to CK-2017357 for the Treatment of Amyotrophic Lateral Sclerosis
February 23, 2010
Cytokinetics Announces Non-Clinical Data from Multiple Programs Presented at the Biophysical Society 54th Annual Meeting
February 12, 2010
Cytokinetics Announces Non-Clinical Data from Multiple Programs to be Presented at the Biophysical Society 54th Annual Meeting
February 3, 2010
Cytokinetics, Incorporated Reports Fourth Quarter and Year End 2009 Financial Results
February 1, 2010
Cytokinetics to Present at BIO CEO and Investor Conference
January 27, 2010
Cytokinetics to Announce Fourth Quarter and Year End Results On February 3, 2010
January 27, 2010
Cytokinetics Announces Data From Phase I Multiple Dose Clinical Trial of CK-2017357
January 11, 2010
Cytokinetics Announces Positive Data From Phase I Clinical Trial of CK-2017357
